Business, energy, technology, markets and global industry news from Business News Today

blood-brain barrier

Features & Analysis

Why the blood-brain barrier keeps powerful drugs out of the brain and how brain shuttles are starting to break through

The blood-brain barrier protects neurons by tightly controlling molecular traffic, but the same biology excludes many antibodies, enzymes and nucleic-acid medicines. Drug developers are increasingly hijacking the barrier’s own transport systems rather than trying simply to disrupt it.

Read More
Pharma & Biotech

Why the Nona Biosciences and Lonza alliance matters for brain-penetrant biologics

Nona Biosciences and Lonza are building a single-domain antibody platform to cross the blood-brain barrier. Explore the clinical and licensing stakes.

Read More
Pharma & Biotech

Curatis licenses corticorelin to Neupharma in CHF 83.5m Japan deal

Curatis and Neupharma sign a CHF 83.5m Japan licensing deal for corticorelin in peritumoral brain edema. Read our analysis of what the deal means.

Read More
Pharma & Biotech

Why Daiichi Sankyo is betting early on SylamoreBio’s SyLEC delivery platform for CNS programs

SylamoreBio partners with Daiichi Sankyo to test SyLEC CNS delivery technology. Find out what this collaboration changes for brain drug development.

Read More